ANNA RICHO

CIK 1199306 · SVP & CCO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$19.93M

Companies

4

Total Filings

51

Lifetime Open-Market Net

-$8.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ILMN Director 8,527 $160.97 $1.37M $0 3 2026-05-22
EXCw Director 11,337 $0 12 2026-04-29
Adamas Pharmaceuticals Inc (ADMS) Delisted Director 0 $8.22 $0 $0 3 2021-11-24
AMGN SVP & CCO 52,248 $355.20 $18.56M -$8.53M 33 2012-08-01

Recent Filings · Page 4 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-03-15 AMGN Mixed −903 -$46.8K EDGAR
2011-03-04 AMGN Grant (A) +2,460 $0 EDGAR
2010-10-29 AMGN Grant (A) +20,000 $0 EDGAR
2010-10-27 AMGN Mixed -$87.4K EDGAR
2010-08-31 AMGN Sell (S) −3,000 -$157.0K EDGAR
2010-08-03 AMGN Mixed −917 -$50.0K EDGAR
2010-06-03 AMGN Disp (D) −2,000 -$110.3K EDGAR
2010-04-30 AMGN Mixed −833 -$48.3K EDGAR
2010-04-28 AMGN Grant (A) +5,800 $0 EDGAR
2010-03-16 AMGN Mixed +1,500 -$50.0K EDGAR
Showing 3140 of 51
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.